Prehabilitation and Immunonutrition in Pancreatic Cancer Therapy.

Madeline Roorbach, Whitney Bleakley, Maria C Russell

Journal: Surgical oncology clinics of North America 2025;35(1):55-69

PMID: 41233073

Full Text on W.B. Saunders View on PubMed

Abstract

Pancreatic cancer is an aggressive disease with demanding therapies. Patients often present physically and nutritionally debilitated and then are required to undergo rigorous chemotherapy and/or chemoradiation, as well as operative interventions. Ensuring that patients are physically, nutritionally, and psychosocially supported may promote tolerance of neoadjuvant treatments to ensure progression to and success of surgery.

Address: Department of Surgery, Emory University, Atlanta, GA, USA.; Winship Cancer Institute, Emory University, Atlanta, GA, USA.; Division of Surgical Oncology, Department of Surgery, Emory University, Atlanta, GA, USA. Electronic address: [email protected].

DOI: 10.1016/j.soc.2025.03.004

Link outs

Free resources

Medical:

https://medlineplus.gov/pancreaticcancer.html

Subscription / membership required

Full Text Sources:

http://journals.elsevierhealth.com/retrieve/pii/S1...

MeSH Terms: Humans, Pancreatic Neoplasms, Immunotherapy, Preoperative Care, Neoadjuvant Therapy, Preoperative Exercise, Immunonutrition Diet